Vimarsana
Biggest News Aggregation in the World

Allakos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allakos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allakos Today - Breaking & Trending Today

Allakos Inc. (NASDAQ:ALLK) Given Consensus Recommendation of "Hold" by Analysts - Vimarsana News

Allakos Inc. (NASDAQ:ALLK) Given Consensus Recommendation of "Hold" by Analysts

Allakos Inc. (NASDAQ:ALLK – Get Free Report) has received a consensus rating of “Hold” from the seven research firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company. The […]

Source: wkrb13.com
Allakos (NASDAQ:ALLK) Lowered to Hold at Jefferies Financial Group - Vimarsana News

Allakos (NASDAQ:ALLK) Lowered to Hold at Jefferies Financial Group

Allakos (NASDAQ:ALLK – Get Free Report) was downgraded by Jefferies Financial Group from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Briefing.com reports. They presently have a $1.50 price target on the stock, down from their previous price target of $6.00. Jefferies Financial Group’s price […]

Source: wkrb13.com
Allakos Skin Drug Fails 2 Mid-Stage Tests, Sparks Restructuring to Cut 50% of Staff - Vimarsana News

Allakos Skin Drug Fails 2 Mid-Stage Tests, Sparks Restructuring to Cut 50% of Staff

Allakos’s lirentelimab did not beat a placebo in separate Phase 2 tests in atopic dermatitis and spontaneous chronic urticaria. A restructuring now turns the biotech’s focus to an early-stage drug candidate also designed to treat inflammation.

Allakos Inc. (NASDAQ:ALLK) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - Vimarsana News

Allakos Inc. (NASDAQ:ALLK) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Allakos Inc. (NASDAQ:ALLK – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven research firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating […]

Allakos Inc. (NASDAQ:ALLK) Sees Large Growth in Short Interest - Vimarsana News

Allakos Inc. (NASDAQ:ALLK) Sees Large Growth in Short Interest

Allakos Inc. (NASDAQ:ALLK – Get Free Report) was the target of a significant increase in short interest in the month of November. As of November 30th, there was short interest totalling 3,780,000 shares, an increase of 10.2% from the November 15th total of 3,430,000 shares. Based on an average trading volume of 1,010,000 shares, the […]